NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp · Healthcare · Market cap $14.2M
Insiders bought $35K net in the last 90 days ·1 seller, 1 buyer· latest Form 4 filed Sep 8, 2026
Insider Buying
$737K
reported purchases (SEC code P)
Insider Selling
$55K
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Latest filing
Sep 8, 2026
Wambeke David J.
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) has 22 SEC Form 4 filings (25 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Sep 8, 2026.
Inside the rolling window, 2 insiders at NEUROONE MEDICAL TECHNOLOGIES Corp reported 2 open-market purchases totaling $737K and 6 open-market sales totaling $55K. The most active filer is Market Development Director Christianson Mark with 6 filings. The most recent open-market filing is a purchase of 33,333 shares by Chief Business Officer Wambeke David J., dated Aug 27, 2026, worth $67K.
- Industry:Medical - Devices
- CEO:David A. Rosa
- Employees:18
- HQ:Eden Prairie, MN, US
- IPO:2018-03-15
| Source | |||||||
|---|---|---|---|---|---|---|---|
Wambeke David J.First in 6 months | Chief Business Officer | Purchase | 33,333 | $67K | Sep 8 | -7.7% | SEC ↗ |
Christianson MarkFirst in 3 months | Market Development Director | Sale | 10,000 | $32K | Jul 2 | -48.0% | SEC ↗ |
| Business Development Director | Sale | 15,363 | $11K | Apr 1 | -67.6% | SEC ↗ | |
| Business Development Director | Sale | 817 | $654 | Mar 16 | -63.9% | SEC ↗ | |
| Business Development Director | Sale | 100 | $80 | Mar 16 | -63.9% | SEC ↗ | |
Christianson MarkFirst filing | Business Development Director | Sale | 11,611 | $9K | Mar 12 | -67.0% | SEC ↗ |
Christianson MarkFirst filing | Business Development Director | Sale | 2,109 | $2K | Mar 12 | -67.0% | SEC ↗ |
Wambeke David J.First filing | Chief Business Officer | Purchase | 1,000,000 | $670K | Mar 3 | -67.9% | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does NMTC have?
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) has 22 SEC Form 4 filings (25 transaction rows) in the rolling 365-day window, disclosed by 2 distinct insiders. Most recent filing: Sep 8, 2026.
When was the most recent SEC Form 4 filing for NMTC?
The most recent Form 4 filing for NMTC on Tracefour is dated Sep 8, 2026.
Who is the most active insider at NMTC?
The most active SEC Form 4 filer at NMTC in the rolling window is Market Development Director Christianson Mark, with 6 filings.
What is the net insider flow at NMTC over the last 6 months?
Over the trailing 180 days, insiders at NMTC have net bought $23K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at NMTC in the current window?
Inside the rolling window, insiders at NMTC bought $737K and sold $55K based on SEC Form 4 filings.
Can I get alerts for NMTC insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
NEUROONE MEDICAL TECHNOLOGIES Corp is in the Healthcare sector.